Matignon Technologies

Matignon Technologies is a French venture capital firm that focuses on early-stage investments in innovative, unlisted companies within the technology and healthcare sectors. The firm operates as a closed-end fund with a capital of €50 million, investing as a minority shareholder with stakes ranging from €500,000 to €3 million. The fund's lifespan is six years, with subscriptions having closed in September 2000.

The firm's investment strategy emphasizes identifying and supporting high-growth potential companies in the technology and healthcare industries. By providing capital and strategic guidance, Matignon Technologies aims to foster innovation and drive the success of its portfolio companies. The firm has a history of investing in various sectors, including biotechnology, medical devices, and life sciences.

Matignon Technologies has been active in the venture capital landscape since its inception, contributing to the growth and development of numerous startups. Its approach combines financial support with a commitment to nurturing entrepreneurial talent, reflecting a philosophy centered on long-term value creation and sustainable growth.